Lacor, P.

patient response t-cell vaccine study antigen vaccination t-cell responses infection t cells electroporated protein trial dendritic assay control elispot interruption dendritic cells count autologou therapy number virus immunol value dc electroporated treatment t-cell count chimeric nef-specific t-cell responses t-cell counts result treatment interruption cd 4+ analysis dc-based brussel chimeric mrna time points hiv-speci allard encoding phase cytokine mrna encoding proliferation method blood peptide antiretroviral hiv -1-infected patients antiretroviral therapy chimeric protein immunotherapy nef-specific hiv infection event dc-based elispot replication regression dc-based elispot assay cytotoxic proliferative vaccine-specific t-cell responses peptide-based elispot assay -1-infected ifn -γ production laboratory cart resumption hiv-infected patients increase point disease sfu /million pbmcs cfse proliferation assays change regression analysis stimulation hla class i